DePuy Synthes Products, Inc.
$101.4M 2,547 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Boston Scientific Corporation
Boston Scientific Corporation reported $99,797,223.13 across General Payments, Research, and Ownership to 271,484 physicians and teaching hospitals across 278,290 transactions.
- $99.8M
- All-tracks total
- 278,290
- Transactions
- 271,484
- Recipients
- +$15.3M
- General Payments vs PY2023
Boston Scientific Corporation reported $99,797,223.13 across all CMS Open Payments tracks (General + Research + Ownership) to 271,484 physicians and teaching hospitals in Program Year 2024 - ranking #27 of 1,925 reporting manufacturers (0.7% of the all-tracks industry total); General Payments alone were $61,770,891.52, averaging $367.60 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer boston-scientific-corporation Boston Scientific Corporation
$99.8M · #27/1,925 · 0.7% industry · PY2024
- TOT $99.8M
- RANK #27
- SHARE 0.7%
- TXN 278,290
- RCP 271,484
- CAT 10
- GEN $61.8M
- ΔGEN +$15.3M
- TOP1 3.0%
- PY 2024
Volume peers
Nearest volume peer: DePuy Synthes Products, Inc. ($101.4M)
Boston Scientific Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Boston Scientific Corporation's CMS-reported General Payments increased by $15.3M (+33.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BOSTON SCIENTIFIC CORPORATIONPY2023: BOSTON SCIENTIFIC CORPORATIONPY2024: Boston Scientific Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $46,425,640.00
- PY2024
- $61,770,891.52
What the Data Shows for Boston Scientific Corporation
$99,797,223.13: that is what Boston Scientific Corporation reported in payments to 271,484 physicians and teaching hospitals during Program Year 2024, spread across 278,290 transactions ($358.61 per transaction, $367.60 per recipient). The company sits at rank #27 of 1,925, representing 0.7% of all industry payments reported nationwide for the year.
Of the 10 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $16.8M across 8,775 transactions, 27.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Boston Scientific Corporation's 10-category general-payment breakdown at $16.8M, 27.2% of the reported total.
Boston Scientific Corporation reports 10 general-payment categories - the top three are Compensation for Services Other Than Consulting (27.2%), Grant (25.7%), and Food and Beverage (17.1%). The remaining 7 categories make up 30.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Boston Scientific Corporation files across 10 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Boston Scientific Corporation divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $16.8M | 8,775 | 27.2% |
| Grant | $15.8M | 1,037 | 25.7% |
| Food and Beverage | $10.6M | 238,101 | 17.1% |
| Consulting Fee | $7.3M | 3,347 | 11.8% |
| Travel and Lodging | $5.8M | 19,905 | 9.4% |
| Acquisitions | $4.6M | 16 | 7.5% |
| Royalty or License | $490.8K | 3 | 0.8% |
| Long-Term Medical Supply or Device Loan | $281.3K | 48 | 0.5% |
| Charitable Contribution | $48.6K | 92 | 0.1% |
| Education | $23.6K | 160 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $6,829,821.69 (11.1%) of $61,770,891.52 in this company's General Payments records across 71,173 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Boston Scientific Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Rahmi Oklu
$1,876,487.25 across 58 reported transactions
- 2
U Of U Hospitals & Clinics
$1,752,660.85 across 8 reported transactions
- 3
Washington Hospital Center
$1,102,239.68 across 46 reported transactions
- 4
Ashok Reddy
$1,054,832.11 across 2 reported transactions
- 5
Adventhealth Orlando
$1,043,601.80 across 21 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Boston Scientific Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Boston Scientific Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Boston Scientific Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Genzyme Corporation
$97.0M 182,526 recipients
Compare payment profiles
Edwards Lifesciences Corporation
$93.0M 70,149 recipients
Compare payment profiles
Abbott Laboratories
$91.7M 292,558 recipients
Compare payment profiles
Arthrex, Inc.
$109.0M 49,842 recipients
Compare payment profiles
Vertex Pharmaceuticals Incorporated
$109.6M 10,996 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.